文献速递腹部MR

复发性肝细胞癌诊断:钆塞酸增强MRI与细胞外对比剂增强MRI的个体内比较

Diagnosis of recurrent HCC: intraindividual comparison of gadoxetic acid MRI and extracellular contrast-enhanced MRI.
PubMed 文献 · Abdom Radiol (NY) · 2019-01-01

本回顾性研究纳入135例经2-5次治疗(手术、经动脉化疗栓塞和/或射频消融)后疑似肝细胞癌复发的患者,均在1个月内先后接受钆塞酸增强MRI(HBA-MRI)和细胞外对比剂增强MRI(ECA-MRI)检查。共识别136个肝脏病灶(121个肝细胞癌、15个良性病灶,中位大小1.9 cm)。ECA-MRI对肝细胞癌复发的敏感度和准确率均优于HBA-MRI,两位观察者结果一致。作者据此认为,在评估多次治疗后的肝细胞癌复发时,ECA-MRI可作为优于HBA-MRI的首选影像方法。

要点

  • ECA-MRI对复发性肝细胞癌的敏感度和准确率均显著高于HBA-MRI。
  • 两位观察者间一致性ECA-MRI为优(0.885),HBA-MRI为相当(0.749)。
  • 12.4%的肝细胞癌(15个)被ECA-MRI正确诊断而HBA-MRI未检出。

核心结论

  • 对于多次治疗后的复发性肝细胞癌检测,ECA-MRI在敏感度和准确率方面均优于HBA-MRI。
  • 作者认为,在评估多次治疗后的肝细胞癌复发时,ECA-MRI可作为优于HBA-MRI的首选影像方法。

研究设计与样本

  • 回顾性研究,经机构审查委员会批准并豁免患者知情同意。
  • 共纳入135例经2-5次治疗(手术、经动脉化疗栓塞和/或射频消融)后疑似肝细胞癌复发的患者。
  • 所有患者均在1个月间隔内先后接受HBA-MRI和ECA-MRI检查。
  • 由两位观察者采用五分法对HBA-MRI和ECA-MRI进行肝细胞癌检测分析,并比较不同MRI方法的诊断效能。

诊断标准与关键数值

  • 共识别136个肝脏病灶,包括121个肝细胞癌和15个良性病灶,中位大小1.9 cm。
  • 敏感度:观察者1 ECA-MRI 90.9% vs HBA-MRI 76.9%;观察者2 ECA-MRI 91.7% vs HBA-MRI 78.5%(P=0.002, 0.003)。
  • 准确率:观察者1 ECA-MRI 91.2% vs HBA-MRI 78.7%;观察者2 ECA-MRI 91.9% vs HBA-MRI 80.2%(P=0.002, 0.003)。
  • 15个(12.4%)肝细胞癌被两位观察者用ECA-MRI正确诊断而HBA-MRI未检出。
  • 观察者间一致性:ECA-MRI为优(0.885),HBA-MRI为相当(0.749)。

临床应用与阅片要点

  • 在评估多次治疗后的肝细胞癌复发时,作者认为ECA-MRI可作为优于HBA-MRI的首选影像方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To compare the efficacy of magnetic resonance imaging (MRI) with hepatobiliary agents (HBA-MRI) and MRI with extracellular contrast agents (ECA-MRI) for detection of recurrent hepatocellular carcinoma (HCC) after multiple treatments.

METHODS: The institutional review board approved this retrospective study and waived the requirement for informed patient consent. A total of 135 patients with suspected HCC recurrence after 2-5 treatments (surgery, transarterial chemoembolization, and/or radiofrequency ablation) underwent both HBA-MRI and ECA-MRI within a 1 month interval. HBA-MRI and ECA-MRI were analyzed for HCC detection by two observers using a five-point scale. The diagnostic performances according to MRI modality were compared.

RESULTS: A total of 136 liver lesions (121 HCCs and 15 benign lesions; median size, 1.9 cm) were identified. ECA-MRI showed greater sensitivity (90.9% vs. 76.9% for observer 1; 91.7% vs. 78.5% for observer 2) and accuracy (91.2% vs. 78.7% for observer 1; 91.9% vs. 80.2% for observer 2) than HBA-MRI for both observers (P = 0.002, 0.003). Fifteen (12.4%) HCCs were correctly diagnosed with ECA-MRI but not with HBA-MRI by both observers. Interobserver agreement was excellent (0.885) for ECA-MRI and substantial (0.749) for HBA-MRI.

CONCLUSIONS: For detection of recurrent HCC, ECA-MRI was superior to HBA-MRI in terms of sensitivity and accuracy. Therefore, ECA-MRI could be the preferred imaging modality over HBA-MRI for assessing HCC recurrence following multiple treatments.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Yim JH, Kim YK, Min JH, et al. Diagnosis of recurrent HCC: intraindividual comparison of gadoxetic acid MRI and extracellular contrast-enhanced MRI. Abdom Radiol (NY). 2019. PMID: 30847566. doi:10.1007/s00261-019-01968-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。